Cytokine abnormalities in a patient with eosinophilic fasciitis

Annals of Allergy, Asthma and Immunology

Volumn 90, Issue 4, 2003, Pages 452-455

  Dziadzio, Laura ^a   Kelly, Elizabeth A ^a   Panzer, Sarah E ^a   Jarjour, Nizar ^a   Huttenlocher, Anna ^a,b,c  

^a University of Wisconsin Health   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c Department of Pharmacology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 5; PREDNISONE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; ATOPY; CASE REPORT; DOSE CALCULATION; EOSINOPHILIC FASCIITIS; FEMALE; FOREARM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SERUM; SYMPTOMATOLOGY;

EID: 0037391893     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61832-7     Document Type: Article

References (22)

1. Shulman L. Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: a new syndrome. J Rheumatol 1974;1:46.
2. Grisanti MW, Moore TL, Osborn TG, Haber PL. Eosinophilic fasciitis in children. Semin Arthritis Rheum 1989;19:151-157.
3. Kelly EA, Rodriguez RR, Busse WW, Jarjour NN. The effect of segmental bronchoprovocation with allergen on airway lymphocyte function. Am J Respir Crit Care Med 1997;156:1421-1428.
4. Rothenberg ME. Eosinophilia. N Engl J Med 1998;338: 1592-1600.
5. Shah A, Panjabi C. Allergic bronchopulmonary aspergillosis: a review of a disease with a worldwide distribution. J Asthma 2002;39:273-289.
6. Nelson AM. Localized scleroderma including morphea, linear scleroderma, and eosinophilic fasciitis. Curr Probl Pediatr 1996; 26:318-324.
7. Farrington ML, Haas JE, Nazar-Stewart V, Mellins ED. Eosinophilic fasciitis in children frequently progresses to scleroderma-like cutaneous fibrosis. J Rheumatol 1993;20:128-132.
8. Balat A, Akinci A, Turgut M, et al. Eosinophilic fasciitis-progression to linear scleroderma: a case report. Turk J Pediatr 1999;41: 381-385.
9. Stork J, Nemcova D, Hoza J, Kodetova D. Eosinophilic fasciitis in an adolescent girl with lymphadenopathy and vitiligo-like and linear scleroderma-like changes. A case report. Clin Exp Rheumatol 1996;14:337-341.
10. Williams HJ, Ziter FA, Banta CA. Childhood eosinophilic fasciitis-progression to linear scleroderma. J Rheumatol 1986;13: 961-962.
11. Lakhanpal S, Ginsburg WW, Michet CJ, et al. Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 1988;17:221-231.
12. Naschitz JE, Misselevich I, Rosner I, et al. Lymph-node-based malignant lymphoma and reactive lymphadenopathy in eosinophilic fasciitis. Am J Med Sci 1999;318:343-349.
13. Clauw DJ, Crofford LJ. Eosinophilic rheumatic disorders. Rheum Dis Clin North Am 1995;21:231-246.
14. Godding V, Bodart E, Delos M, et al. Mechanisms of acute eosinophilic inflammation in a case of acute eosinophilic pneumonia in a 14-year-old girl. Clin Exp Allergy 1998;28:504-509.
15. Kondo S, Yazawa H, Jimbow K. Reduction of serum interleukin-5 levels reflect clinical improvement in patients with atopic dermatitis. J Dermatol 2001;28:237-243.
16. Matsumoto T, Goto Y, Miike T. Markedly high eosinophilia and an elevated serum IL-5 level in an infant with cow milk allergy. Ann Allergy Asthma Immunol 1999;82:253-256.
17. Shikiji T, Urano Y, Takiwaki H, Arase S. A case of episodic angioedema associated with eosinophilia. J Med Invest 1997; 44:103-108.
18. Hayashi M, Ohashi Y, Tanaka A, et al. Suppression of seasonal increase in serum interleukin-5 is linked to the clinical efficacy of immunotherapy for seasonal allergic rhinitis. Acta Otolaryngol Suppl 1998;538:133-142.
19. Nishiya K, Tanimoto N, Hashimoto K, et al. Serum and synovial fluid levels of interleukin-5 in a patient with eosinophilic fasciitis. Ann Rheum Dis 1996;55:935-936.
20. Barnard JA, Lyons RM, Moses HL. The cell biology of transforming growth factor β. Biochem Biophys Acta 1990;1032: 79-87.
21. Varga J, Veli-Matti K. Eosinophilia-myalgia syndrome, eosinophilic fasciitis, and related fibrosing disorders. Curr Opin Rheumatol 1997;9:562-570.
22. Kahari L, Jiminez S. Increased expression of transforming growth factor-β1, fibronectin, and types I, III, and VI collagen genes in fascial fibroblasts from patients with diffuse fasciitis with eosinophilia. J Rheumatol 1996;23:482-486.